Article
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.
Inflammatory bowel diseases - 1 Oct 2017
Bramuzzo Matteo, Stocco Gabriele, Montico Marcella, Arrigo Serena, Calvi Angela, Lanteri Paola, Costa Stefano, Pellegrino Salvatore, Magazzù Giuseppe, Barp Jacopo, Ghione Silvia, Lionetti Paolo, Zuin Giovanna, Fontana Massimo, Di Chio Teresa, Maggiore Giuseppe, Lazzerini Marzia, Lucafò Marianna, Udina Chiara, Pellegrin Maria Chiara, Chicco Andrea, Carrozzi Marco, Decorti Giuliana, Ventura Alessandro, Martelossi Stefano
Abstract excerpt
BACKGROUND: Thalidomide is an effective therapy in children with inflammatory bowel disease refractory to standard treatments, but thalidomide-induced peripheral neuropathy (TiPN) limits its long-term use. We aimed to investigate the risk factors and the outcome of TiPN in children with inflammatory bowel disease. METHODS: Within a retrospective multicenter cohort study, we evaluated prevalence and evolution of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
